(Q73276246)

English

Effect of a cyclic heptapeptide based on the human CD4 domain 1 CC' loop region on murine experimental allergic encephalomyelitis: inhibition of both primary and secondary responses

scientific article published on 01 January 2001

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Effect of a cyclic heptapeptide based on the human CD4 domain 1 CC' loop region on murine experimental allergic encephalomyelitis: inhibition of both primary and secondary responses (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

author name string

A E Edling

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

S Choksi

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Z Huang

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

R Korngold

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

publication date

1 January 2001

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Journal of Neuroimmunology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

112

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

1-2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

115-128

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Identification of a CD4 binding site on the beta 2 domain of HLA-DR molecules.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Therapy with monoclonal antibodies by elimination of T-cell subsets in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reverse ELISPOT assay for clonal analysis of cytokine production I. Enumeration of gamma-interferon-secreting cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interaction between CD4 and class II MHC molecules mediates cell adhesion

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identification of a human CD4-CDR3-like surface involved in CD4+ T cell function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of severe systemic lupus erythematosus with anti-CD4 monoclonal antibody

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. I. Clinical results of a multicenter, randomized, double-blind, placebo-controlled trial. The IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Intramuscular interferon beta-1a for disease progression in relapsing multiple sclerosis. The Multiple Sclerosis Collaborative Research Group (MSCRG)

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Copolymer 1 reduces relapse rate and improves disability in relapsing-remitting multiple sclerosis: results of a phase III multicenter, double-blind placebo-controlled trial. The Copolymer 1 Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Thymic selection of CD8+ single positive cells with a class II major histocompatibility complex-restricted receptor

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

MHC class II interaction with CD4 mediated by a region analogous to the MHC class I binding site for CD8

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Involvement of both major histocompatibility complex class II alpha and beta chains in CD4 function indicates a role for ordered oligomerization in T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Acute experimental allergic encephalomyelitis in radiation bone marrow chimeras between high and low susceptible strains of mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

B7-1 and B7-2 costimulatory molecules activate differentially the Th1/Th2 developmental pathways: application to autoimmune disease therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

CD4 dimerization and oligomerization: implications for T-cell function and structure-based drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Th1 and Th2 CD4+ T cells in the pathogenesis of organ-specific autoimmune diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Repeated treatment with chimeric anti-CD4 antibody in multiple sclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The efficiency of CD4 recruitment to ligand-engaged TCR controls the agonist/partial agonist properties of peptide-MHC molecule ligands

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Differential recognition of peptide analogs by naive verses activated PLP 139-151-specific CD4+ T cells

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Inflammatory leukocytes and cytokines in the peptide-induced disease of experimental allergic encephalomyelitis in SJL and B10.PL mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Delineation of an extended surface contact area on human CD4 involved in class II major histocompatibility complex binding

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Surface proteins involved in T cell costimulation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Death of mature T cells by separate ligation of CD4 and the T-cell receptor for antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Coaggregation of the T-cell receptor with CD4 and other T-cell surface molecules enhances T-cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Interferon beta-1b is effective in relapsing-remitting multiple sclerosis. II. MRI analysis results of a multicenter, randomized, double-blind, placebo-controlled trial. UBC MS/MRI Study Group and the IFNB Multiple Sclerosis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Tolerance induction in double specific T-cell receptor transgenic mice varies with antigen

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of multiple sclerosis with anti-CD4 monoclonal antibody. A preliminary report on B-F5 in 21 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment with depleting CD4 monoclonal antibody results in a preferential loss of circulating naive T cells but does not affect IFN-gamma secreting TH1 cells in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Oligomerization of CD4 is required for stable binding to class II major histocompatibility complex proteins but not for interaction with human immunodeficiency virus gp120

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Molecular recognition of antigen involves lattice formation between CD4, MHC class II and TCR molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Synthetic peptides derived from the fourth domain of CD4 antagonize off function and inhibit T cell activation

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Bioactive peptide design based on protein surface epitopes. A cyclic heptapeptide mimics CD4 domain 1 CC' loop and inhibits CD4 biological function

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

A cell culture model for T lymphocyte clonal anergy

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Copolymer 1: from basic research to clinical application

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Multiple Sclerosis: Distribution of T Cell Subsets Within Active Chronic Lesions

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Myelin proteolipid protein induces demyelinating disease in mice

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric CD4 monoclonal antibody cM-T412 as a therapeutic approach to rheumatoid arthritis

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The adoptive transfer of chronic relapsing experimental allergic encephalomyelitis with lymph node cells sensitized to myelin proteolipid protein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment of multiple sclerosis with the monoclonal anti-CD4 antibody cM-T412: results of a randomized, double-blind, placebo-controlled, MR-monitored phase II trial

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

The CD4 and CD8 T cell surface antigens are associated with the internal membrane tyrosine-protein kinase p56lck

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Reversal of experimental allergic encephalomyelitis with monoclonal antibody to a T-cell subset marker

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunosuppression by anti-CD4 treatment in vivo. Persistence of secondary antiviral immune responses.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Immunosuppression by anti-CD4 treatment in vivo. Cellular and humoral responses to alloantigens.

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Dimeric association and segmental variability in the structure of human CD4

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Passive transfer of experimental allergic encephalomyelitis induced by proteolipid apoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0165-5728%2800%2900393-3

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0165-5728(00)00393-3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11108940%20AND%20SRC:MED&resulttype=core&format=json

2 November 2019

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q73276246&oldid=1911750776"